TLR9 and chronic kidney disease: An animal study demonstrated that systemic exposure to CpG-DNA 1668, one of the TLR9 ligand, increases CD11b + /Ly6Chi macrophages and induces classically activated renal M1 macrophages that enhance intrarenal inflammation and disease progression of Alport nephropathy and other types of chronic kidney diseases (128).